QA: Akorn INC in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000003116_2013_Akorn_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000003116, Akorn INC

  xvar xval
0 AssetsCurrent 158,707,000
1 IntangibleAssetsNetIncludingGoodwill 95,813,000
2 PropertyPlantAndEquipmentNet 80,679,000
3 remainder_Assets 34,366,000
4 LiabilitiesCurrent 43,291,000
5 LiabilitiesNoncurrent 125,193,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 107,466,000
8 SellingGeneralAndAdministrativeExpense 48,053,000
9 ResearchAndDevelopmentExpense 15,858,000
10 remainder_Expenses 45,365,000
11 remainder_Revenues 256,158,000
12 remainder_NetIncome -4,038,000
13 remainder_ComprehensiveNetIncome -5,904,000
  yvar yval
0 Assets 369,565,000
1 Liabilities 168,484,000
2 Expenses 216,742,000
3 Revenues 256,158,000
4 StockholdersEquity 201,081,000
5 NetIncome 35,378,000
6 ComprehensiveNetIncome 32,426,000
7 BaseVar 510,445,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.75
9 EconomicCapitalRatio 2.85

Edgar->Model Mapping

Feature Distribution

Change over Time